|
 |
News
- Abbott and Abbott Fund Expand Commitment to Improve Maternal and Child Health in Afghanistan
- Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
- Creator of Glucose Measurement Technology Used In Abbott's Diabetes Care Products Receives National Medal of Technology and Innovation
Features
|
Abbott's Commitment in HIV/AIDS Learn how Abbott is fighting this disease around the world by expanding access to treatment, supporting children affected by the virus, and strengthening health care systems. |
|
"We In The Abbott Family Have An Opportunity To Make a Difference" Abbott and its philanthropic foundation, the Abbott Fund, are working with our humanitarian aid organization partners in providing U.S. $1million in aid in response to the May 12 earthquake in Sichuan Province in China. |
|
XIENCE V™ Wins United States Approval The FDA has approved our XIENCE V drug eluting stent for treatment of coronary artery disease. It will launch in the United States immediately and is expected to become a significant contributor to Abbott’s future performance. |
|
"I Stand with Magic" Public Service Announcements The “I Stand With Magic Program: Part of the Campaign to End Black AIDS,” in partnership with local communities, provides free and confidential HIV testing. Knowing your status and seeking treatment are the first steps in fighting this disease. |
